IMDX
Insight Molecular Diagnostics
IMDX
IMDX
75 hedge funds and large institutions have $59.4M invested in Insight Molecular Diagnostics in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 15 increasing their positions, 26 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
39% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 23
42% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 26
Holders
75
Holding in Top 10
2
Calls
$156K
Puts
–
Top Buyers
| 1 | +$6.75M | |
| 2 | +$5.4M | |
| 3 | +$5.25M | |
| 4 |
Millennium Management
New York
|
+$896K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$324K |
Top Sellers
| 1 | -$2.33M | |
| 2 | -$1.45M | |
| 3 | -$926K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$309K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$264K |